Page last updated: 2024-09-04

ezetimibe and warfarin

ezetimibe has been researched along with warfarin in 6 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(warfarin)
Trials
(warfarin)
Recent Studies (post-2010) (warfarin)
2,4845631,46536,5732,14314,728

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1 Homo sapiens (human)0.0088

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Alton, KB; Bergman, AJ; Johnson-Levonas, AO; Kosoglou, T; Paolini, JF; Statkevich, P1
Leung, AA; van Walraven, C1
Ako, J; Fujiyoshi, K; Hashikata, T; Hashimoto, T; Ishii, S; Kakizaki, R; Kameda, R; Kitasato, L; Namba, S; Nemoto, T; Shimohama, T; Tojo, T; Yamaoka-Tojo, M1

Reviews

3 review(s) available for ezetimibe and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions.
    Clinical pharmacokinetics, 2005, Volume: 44, Issue:5

    Topics: Animals; Anticholesteremic Agents; Azetidines; Biological Availability; Cholestyramine Resin; Contraceptives, Oral; Drug Interactions; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Warfarin

2005
Reviewing the medical literature: five notable articles in general internal medicine from 2010 and 2011.
    Open medicine : a peer-reviewed, independent, open-access journal, 2012, Volume: 6, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Azetidines; Cardiomyopathies; Ezetimibe; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk; Seizures; Simvastatin; Ultrasonography; Warfarin

2012

Other Studies

3 other study(ies) available for ezetimibe and warfarin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.
    Heart and vessels, 2017, Volume: 32, Issue:1

    Topics: Aged; Anticholesteremic Agents; Anticoagulants; Blood Coagulation; Cholesterol, LDL; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; International Normalized Ratio; Japan; Linear Models; Male; Middle Aged; Prothrombin Time; Retrospective Studies; Treatment Outcome; Warfarin

2017